Overall these findings support the view that EGFR contributes to immune escape not only by downregulating tumor cell immunogenicity (signal 1) or providing aberrant signals 2 and 3 but also inducing an acidic, lactate rich milieu that impairs an effective adaptive antitumor immunity. The gene discussed is EGFR; the disease is neoplasm.